Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Intergalactic Therapeutics
40 Guest St
Boston, MA 02135

Intergalactic Therapeutics, an ATP company, is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal C3DNA (covalently closed and circular DNA) molecules; a customized approach to focal therapeutic delivery using its lead delivery technology, the COMET® pulsed electric field system; and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine.

Key Contact
Name
Michael Ehlers, M.D., Ph.D.
Title
Founder & CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
10/07/21 $75,000,000 Series A ATP Fund
undisclosed